NCT05572333 - Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

November 24, 2023

Study Completion Date

November 24, 2023

Conditions

Chronic Obstructive Pulmonary DiseaseCOPD

Interventions

DRUG

EP395

Capsule for oral use

DRUG

Placebo

Capsule for oral use

Trial Locations (6)

Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, Großhansdorf

IKF Pneumologie GmbH & Co. KG Institut für klinische Forschung Pneumologie, Mainz

IKF Pneumologie GmbH & Co. KG, Frankfurt

Bradford Royal Infirmary, Clinical Research Facility, Bradford

Medicines Evaluation Unit Ltd. (MEU), Manchester

Southampton University Faculty of Medicine, Southampton